Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
Harvard Business School
Dow
Moodys

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Cyclopentolate hydrochloride - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cyclopentolate hydrochloride and what is the scope of patent protection?

Cyclopentolate hydrochloride is the generic ingredient in six branded drugs marketed by Akorn, Alcon Labs Inc, Akorn Inc, Alcon Pharms Ltd, Sola Barnes Hind, Bausch And Lomb, and Pharmafair, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for cyclopentolate hydrochloride. Five suppliers are listed for this compound.

Recent Clinical Trials for cyclopentolate hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Eye Disease Prevention and Treatment CenterPhase 4
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 4
Sultan Qaboos UniversityEarly Phase 1

See all cyclopentolate hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for cyclopentolate hydrochloride
Synonyms for cyclopentolate hydrochloride
(+-)-cyclopentolate HCl
(+/-)-Cyclopentolate Hydrochloride
2-(2-(1-Hydroxycyclopentyl)-2-phenylacetoxy)ethyldimethylammonium chloride
2-(Dimethylamino)ethyl (+-)-1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride
2-(dimethylamino)ethyl (1-hydroxycyclopentyl)(phenyl)acetate hydrochloride
2-(Dimethylamino)ethyl 1-Hydroxy-|A-phenylcyclopentaneacetate Hydrochloride
2-(Dimethylamino)ethyl 1-hydroxy-alpha-phenylcyclopentaneacetate hydrochloride
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenyl-acetate hydrochloride
2-(Dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride
2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate;hydrochloride
2-Dimethylaminoethyl 1-hydroxy-|A-phenylcyclopentaneacetate,Cyclopentolate hydrochloride
2-dimethylaminoethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate hydrochloride
5870-29-1
870C291
AC-27486
AC1L2JUE
AK-Pentolate
AKOS015901379
Akpentolate
Alnide
AN-20017
AS-49330
BCP21337
Benzeneacetic acid, ?-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride
Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride
Benzeneacetic acid, alpha-(1-hydroxycyclopentyl)-, 2-(dimethylamino)ethyl ester, hydrochloride, (+-)-
beta-Dimethylaminoethyl (1-hydroxycyclopentyl)phenylacetate hydrochloride
CAS-5870-29-1
CC0260
CCG-39635
CHEBI:4025
CHEMBL1200473
Ciclolux
Cicloplegicedol
Cyclogyl (TN)
Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester, hydrochloride
Cyclopentaneacetic acid, 1-hydroxy-alpha-phenyl-, 2-(dimethylamino)ethyl ester,hydrochloride
Cyclopentolate for system suitability
Cyclopentolate for system suitability, European Pharmacopoeia (EP) Reference Standard
Cyclopentolate HCL
Cyclopentolate hydrochloride (JP17/USP)
Cyclopentolate hydrochloride [USAN:JAN]
Cyclopentolate hydrochloride [USP:JAN]
Cyclopentolate hydrochloride, European Pharmacopoeia (EP) Reference Standard
Cyclopentolate hydrochloride, United States Pharmacopeia (USP) Reference Standard
CyclopentolateHCl
Cyplegin
D01002
DSSTox_CID_25390
DSSTox_GSID_45390
DSSTox_RID_80847
DTXSID9045390
EINECS 227-521-8
FT-0603161
HMS1571K12
HMS1920A22
I14-15042
LS-57811
MLS000069583
MLS001148637
MLS001332539
MLS001332540
Mydplegic
Mydrilate
NCGC00016661-01
NCGC00018213-06
NCGC00094635-01
NCGC00094635-02
NCGC00094635-03
NCGC00094635-04
NSC-756706
NSC756706
Opera_ID_69
Pentolair
Pharmakon1600-01500212
REGID_for_CID_22162
SC-81592
SCHEMBL24612
Skiacol
SMR000058810
SPECTRUM1500212
SR-01000003121
SR-01000003121-4
ST24039645
Tox21_110550
Tox21_110550_1
Y0424
Zyklolat

US Patents and Regulatory Information for cyclopentolate hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd CYCLOPENTOLATE HYDROCHLORIDE cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 089162-001 Jan 24, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Sola Barnes Hind CYCLOPENTOLATE HYDROCHLORIDE cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084150-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair PENTOLAIR cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 088643-001 Feb 9, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Akorn AKPENTOLATE cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 040165-001 Jan 13, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Sola Barnes Hind CYCLOPENTOLATE HYDROCHLORIDE cyclopentolate hydrochloride SOLUTION/DROPS;OPHTHALMIC 084863-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Medtronic
Dow
Baxter
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.